Estimaciones de analistas de Wall Street para Milestone Pharmaceuticals Inc. (MIST): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.20 | ||
| 2026-08-12 | $-0.21 | $-0.20 | -7.7% |
| 2026-05-13 | $-0.20 | $0.06 | -433.3% |
| 2026-03-20 | $-0.16 | $-0.18 | +11.1% |
| 2025-11-12 | $-0.12 | $-0.17 | +29.4% |
| 2025-08-12 | $-0.20 | $-0.18 | -11.1% |
| 2025-05-14 | $-0.31 | $-0.19 | -63.2% |
| 2025-03-13 | $-0.19 | $-0.15 | -26.7% |
Ratios de valoración
| Precio / Valor contable | 5.90 |
| EV / EBITDA | -2.60 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $15.0M | $5.0M | $1.0M | 0 | $1.5M |
| Coste de Ventas | $8000 | $10000 | 0 | 0 | 0 | 0 | 0 | 0 | $114000 |
| Beneficio Bruto | -$8000 | -$10000 | 0 | 0 | $15.0M | $5.0M | $1.0M | 0 | $1.4M |
| I+D | $5.6M | $16.8M | $42.4M | $34.9M | $38.7M | $39.8M | $31.1M | $14.4M | $18.1M |
| Generales y Administrativos | $2.6M | $7.0M | $15.6M | $15.9M | $19.4M | $24.8M | $31.0M | $27.7M | $17.3M |
| Gastos Operativos | $8.3M | $23.8M | $57.9M | $50.7M | $58.1M | $64.6M | $62.1M | $42.1M | $63.9M |
| Beneficio Operativo | -$8.3M | -$23.8M | -$57.9M | -$50.7M | -$43.1M | -$59.6M | -$61.1M | -$42.1M | -$62.5M |
| EBITDA | -$8.3M | -$23.4M | -$57.8M | -$50.6M | -$42.8M | -$58.3M | -$57.0M | -$37.8M | -$59.5M |
| Gastos por Intereses | 0 | 0 | $2.6M | $726000 | 0 | 0 | $2.6M | -$3.6M | $3.8M |
| Beneficio Antes de Impuestos | -$8.1M | -$23.1M | $55.3M | -$50.0M | -$42.9M | -$58.4M | -$59.7M | -$41.5M | -$63.4M |
| Impuestos | $4000 | $74000 | $56000 | -$17000 | 0 | 0 | 0 | 0 | -$345000 |
| Beneficio Neto | -$8.1M | -$23.2M | -$55.2M | -$50.0M | -$42.9M | -$58.4M | -$59.7M | -$41.5M | -$63.1M |
| BPA | $-0.34 | $-0.98 | $-3.50 | $-1.70 | $-1.02 | $-1.35 | $-1.39 | $-0.67 | $-0.75 |
| BPA Diluido | $-0.34 | $-0.98 | $-3.50 | $-1.70 | $-1.02 | $-1.35 | $-1.39 | $-0.67 | $-0.75 |
| Acciones en Circulación (Diluidas) | $23.6M | $23.6M | $15.8M | $29.3M | $41.8M | $42.5M | $43.0M | $62.2M | $83.9M |
Precio
| Precio | $0.89 |
| Capitalización | $111M |
| Bolsa | NASDAQ |
| País | CA |
Empresas relacionadas: APLT · CRBP · CRDF · CYBN · ELTX · IPHA · MOLN
Explorar sector: Healthcare · Biotechnology
Más secciones de MIST: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones